Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06349746
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-05
First Post:
2024-04-01
Brief Title:
Cervical Unilateral Antero-posterior Mobilization and Thoracic Central Postro-anterior Mobilization in Treatment of Shoulder Impingement Syndrome
Sponsor:
Egyptian Chinese University
Organization:
Egyptian Chinese University
Study Overview
Official Title:
The Addition of Cervical Unilateral Antero-posterior Mobilization and Thoracic Central Postro-anterior Mobilization to Selected Therapeutic Exercise Program in Treatment of Shoulder Impingement Syndrome A Randomized Clinical Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Shoulder impingement syndrome SIS is a complex multi-factorial problem that is treated with a variety of different conservative options The conservative option that has shown effectiveness is manual therapy of the cervical and thoracic spine
Detailed Description:
This study will be conducted to answer the following question
What is the effect of adding cervical and thoracic mobilization to selected therapeutic exercise Program on pain intensity Pain-free shoulder flexion and scaption active ROM muscle strength of external rotator and abductors shoulder functional status in patients with Shoulder Impingement Syndrome
What is the effect of adding cervical and thoracic mobilization to selected therapeutic exercise Program on pain intensity Pain-free shoulder flexion and scaption active ROM muscle strength of external rotator and abductors shoulder functional status in patients with Shoulder Impingement Syndrome
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None